ZyVersa Therapeutics, Inc.
USD0.16
-0.00 (-0.06%)
CEO
Stephen C. Glover
IPO Date
2022-02-11
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.16
Prev. Close
$0.16
Day Low
$0.16
Day High
$0.16
52W Low
$0.11
52W High
$1.67
Market Cap
$0.00B
Volume
0.00M
| -0.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -887.6% | -444.5% | 0.00 | 0.33 | -0.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -14.0% | -11.9% | 0.00 | 0.78 | -1.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 64.7% | -717.8% | -0.73 | 0.06 | -19.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 148.2% | -1850.0% | -0.45 | 0.04 | -12.6 |
| -294.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 168.9% | -1903.9% | 0.00 | 0.08 | -0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -36.3% | -11.3% | 0.00 | 0.04 | -3.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -27.8% | -10.8% | 0.00 | 0.18 | -0.2 |
| 31 Dec 2024 | Q4 | 50.0% | -5451.7% | -16.7% | -6.9% | 0.00 | 0.15 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -34.2% | -12.4% | 0.00 | 0.03 | -0.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -32.1% | -14.2% | 0.00 | 0.06 | -0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -25.2% | -13.1% | 0.00 | 0.30 | -0.4 |
| 31 Dec 2023 | Q4 | 83.3% | -85503.2% | -120.4% | -60.3% | 0.00 | 0.33 | -0.1 |